An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review

Vulvar cancer represents approximately 3%–5% of all gynecological malignancies. Squamous cell carcinoma is the most frequent histotype, whereas melanomas, adenocarcinomas, basal cell carcinomas, and sarcomas are much less common. Intestinal-type adenocarcinoma is a rare variant of vulvar carcinoma with only few cases found in the literature. The origin of this neoplasia is still much debated, but the most reliable hypothesis is the origin from cloacal remnants that may persist in the adult in different organs. Because of its extremely low incidence, the optimal management of this kind of vulvar cancer is still debated. We report the case of a woman affected by advanced intestinal-type vulvar adenocarcinoma, who achieved a complete clinical and pathological response after neoadjuvant chemotherapeutic treatment with platinum and paclitaxel.

[1]  B. Terris,et al.  Multiple tubulovillous adenomas of the vulva. , 2012, The American Journal of dermatopathology.

[2]  W. McCluggage,et al.  Intestinal-Type Cervical Adenocarcinoma In Situ and Adenocarcinoma Exhibit a Partial Enteric Immunophenotype With Consistent Expression of CDX2 , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[3]  J. D. de Hullu,et al.  Management of vulvar cancers. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  P. Judson,et al.  Trends in the Incidence of Invasive and In Situ Vulvar Carcinoma , 2006, Obstetrics and gynecology.

[5]  M. Plante,et al.  Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva. , 2004, Human pathology.

[6]  V. Rantanen,et al.  Supra‐additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro , 2002, International journal of cancer.

[7]  F. Nogales,et al.  Villoglandular adenocarcinoma of the vulva. , 2001, Gynecologic oncology.

[8]  M. Conner,et al.  Primary vulvar adenocarcinoma of cloacogenic origin. , 2001, Southern medical journal.

[9]  R. Willén,et al.  Cloacogenic adenocarcinoma of the vulva. , 1999, Gynecologic oncology.

[10]  G. Keeney,et al.  Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  C. Griffiths,et al.  Mucinous adenocarcinomas of the vulva. , 1995, Gynecologic oncology.

[12]  B. Majmudar,et al.  Primary adenocarcinoma of the vulva, possibly cloacogenic. A report of two cases. , 1993, The Journal of reproductive medicine.

[13]  B. Bundy,et al.  Early Stage I Carcinoma of the Vulva Treated With Ipsilateral Superficial Inguinal Lymphadenectomy and Modified Radical Hemivulvectomy: A Prospective Study of the Gynecologic Oncology Group , 1992, Obstetrics and gynecology.

[14]  V. Knutzen,et al.  Primary Adenocarcinoma of the Vulva Originating in Misplaced Cloacal Tissue , 1978, Obstetrics and gynecology.

[15]  L. Resta,et al.  "Intestinal-type" mucinous adenocarcinoma of the vulva: a report of two cases. , 2012, European journal of gynaecological oncology.

[16]  F. Lee,et al.  Cloacogenic adenocarcinoma of the vulva presenting as recurrent Bartholin's gland infection. , 2003, Journal of the Formosan Medical Association = Taiwan yi zhi.

[17]  Tiltman Aj,et al.  Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue. , 1978 .